Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances XBP Q1 2026 Earnings Massive EPS Miss Overshadowed by Stock Rally OTLY Q1 2026 Earnings Losses Narrow Sharply as Cost Improvements Exceed Expectations ECCC Q4 2025 Earnings Preferred Stock Delivers EPS Beat Amid Stable Portfolio Performance RPAY Q1 2026 Earnings Earnings Per Share Surpasses Expectations REKR Q1 2026 Earnings EPS Misses Estimates Revenue Data Unavailable